Angelo Gordon & Co’s Verona Pharma VRNA Stock Holding History

Angelo Gordon & Co’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-145,000	Closed	-$15.5M	–	71
2025 Q3	$15.5M	Buy	+145,000	New	+$15.1M	1.89%	19

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Angelo Gordon & Co's VRNA Position: Q4 2025 in Review

Angelo Gordon & Co sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 145,000 shares — an estimated $15.5M sold.

Angelo Gordon & Co first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $15.5M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Angelo Gordon & Co reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Angelo Gordon & Co sold 145,000 Verona Pharma shares in Q4 2025, an estimated $15.5M.
Angelo Gordon & Co first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Angelo Gordon & Co's Verona Pharma position peaked at $15.5M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Angelo Gordon & Co's 13F filing for Q4 2025, filed 17 Feb 2026.